Clin2
NCT07156916Likely a fitRecruiting

Tamsulosin tablet comparison study in healthy men

Healthy Volunteer Male Subjects

Treatments studied

This trial tests how a new tamsulosin tablet (used for prostate problems) compares to the standard drug in healthy men. You will take one dose and have blood samples taken to measure the drug levels.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
46 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are a healthy man between 18 and 45 years old.
  • You have not smoked for at least 3 months.
  • Your body weight is between 110 and 264 pounds, and your BMI is between 18.5 and 30.
  • You are willing to avoid intercourse or use a condom plus spermicide during the study and for 30 days after.
  • You have no allergies to tamsulosin or similar drugs, and no history of certain eye or heart conditions.
  • You avoid caffeine, citrus fruits, and cranberry for 3 days before the study, and do not take other medications or supplements.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07722884Recruiting
Tamsulosin alone or with tadalafil for enlarged prostate symptoms

This study tests whether taking tadalafil (at 2.5 mg or 5 mg) along with tamsulosin is better for treating urinary symptoms caused by an enlarged prostate than taking tamsulosin alone. It aims to find the best dose combination to improve your quality of life.

Cairo, Cairo Governorate
NCT07467343Not yet recruiting· Phase 4
Silodosin vs tamsulosin for enlarged prostate symptoms

This trial compares two medications, silodosin and tamsulosin, to see which one works better for men with frequent or difficult urination caused by an enlarged prostate. All participants will try both medicines at different times to find the best option.

Cairo
NCT07743034Not yet recruiting· Phase 4
Comparing how two prostate medicines affect the eye

This study compares two prostate medications (tamsulosin and silodosin) to see how they might affect the iris — the colored part of your eye. It may help doctors choose the best option for men who also have concerns about their eyes.

NCT07146386Not yet recruiting· Phase 3
New tablet vs standard medicine for enlarged prostate

This trial tests a new, once-daily tablet (H077) compared to the standard medicine silodosin for treating symptoms of an enlarged prostate. It aims to see if the new medicine works as well and is safe.

Hefei, Anhui
NCT07308002Not yet recruiting· Phase 4
Intermittent vs daily tamsulosin for enlarged prostate

This study compares taking tamsulosin (a drug that relaxes the prostate) every day vs. only on days when symptoms are bothersome. It aims to see if taking it less often works just as well and causes fewer side effects like problems with ejaculation.

Al Mansurah, Outside U.S./Canada
NCT07643233Not yet recruiting· Phase 1
Comparing Two Versions of a Prostate Medication

This study tests whether two formulations of a prostate medication (AJU-G721 and G721R) work the same way in your body. Researchers give both versions to healthy volunteers to make sure they're equally effective and safe.

Seoul

Hear when a new Healthy Volunteer Male Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.